Four mammalian TIMPs have been identified thus far, among them TIMP2 has been most extensively studied due to its ability to inhibit tumor growth and angiogenesis by a variety of mechanisms independent of direct MMP-inhibition [15], [16], [17]. The gene discussed is TIMP2; the disease is neoplasm.